M

Active Director Director DIN 09311193
DIN 09311193 First appointment Sep 2021 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2021
Shareholding value •••• Premium profile

About Monika

Data last updated:

Monika is a Director at Cell Cross Pharmaceuticals Private Limited (since 2021). The company operates in Healthcare. Cell Cross Pharmaceuticals Private Limited reported revenue of ₹88.9 Lakh (FY 2025).

DIN 09311193
Primary Designation Director
Industry Healthcare
First Appointment 08 Sep 2021
Oldest Company Age 5 yrs
Largest company Cell Cross Pharmaceuticals Private Limited · ₹88.9 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director08 Sep 20212021₹88.9 Lakh (FY 2025)Active

Board colleagues of Monika

NameDINCompanyDesignation
Manju09311042Cell Cross Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Cell Cross Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Monika

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Monika

Monika currently holds 1 directorship: Cell Cross Pharmaceuticals Private Limited (Director, since 08 Sep 2021, revenue ₹88.9 Lakh (FY 2025)).

Monika was first appointed on 08 Sep 2021 as Director at Cell Cross Pharmaceuticals Private Limited.

The current boards of Monika's companies include Manju (Cell Cross Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available